CJC-1295 (No DAC): A Powerful Growth Hormone Pumping Agent
CJC-1295 No DAC, also known as Modified GRF 1-29 (Mod GRF 1-29), is a synthetic, short-acting growth hormone-releasing hormone (GHRH) analog designed to stimulate the body’s natural growth hormone (GH) production. Unlike its long-acting counterpart, CJC-1295 with DAC, this version closely mimics the body’s natural pulsatile release of growth hormone.
CJC-1295 No DAC has gained attention in peptide research for its potential role in supporting muscle growth, fat metabolism, recovery, and healthy aging.
Often combined with Ipamorelin, the two provide a powerful synergy for maximizing growth hormone levels. This blend enhances fat, loss, muscle growth, and recovery, while promoting overall well-being and anti-aging benefits. It is especially beneficial for those looking to improve physical performance, accelerate recovery after exercise, and support healthy aging.
Learn more about this peptide’s fat loss potential by reading our blog post here.
What Is CJC-1295 No DAC?
CJC-1295 No DAC is a modified form of GHRH that signals the pituitary gland to increase growth hormone secretion. By stimulating natural GH release, it may also elevate insulin-like growth factor 1 (IGF-1) levels, which play a key role in tissue repair, muscle development, and metabolic function.
Key Features of CJC-1295 No DAC
Alternative Name: Modified GRF 1-29 (Mod GRF 1-29)
Mechanism of Action: Mimics natural GHRH to trigger endogenous GH release
Half-Life: Approximately 30–60 minutes
Administration: Typically administered via subcutaneous injection
Common Stack: Frequently combined with Ipamorelin for synergistic GH stimulation
CJC-1295 No DAC Half-Life and Pulsatile Release
One of the defining characteristics of CJC-1295 No DAC is its short half-life of 30–60 minutes. Because it does not contain a Drug Affinity Complex (DAC), it does not bind to albumin in the bloodstream.
This results in a shorter duration of action, requiring daily or multiple daily administrations. However, many prefer this version because it supports a more natural, pulsatile growth hormone release pattern, closely resembling the body’s own GH rhythm.
Potential Benefits of CJC-1295 No DAC
Research surrounding this growth hormone peptide suggests potential benefits including:
Support for lean muscle growth
Assistance with fat loss and improved body composition
Enhanced recovery and tissue repair
Support for healthy IGF-1 levels
Possible anti-aging and wellness applications
Because of its short-acting profile, it is often paired with Ipamorelin, a growth hormone secretagogue, to further enhance natural GH output.
Side Effects and Considerations
As with many peptide-based compounds, potential side effects may include:
Injection site irritation (redness, swelling, discomfort)
Flushing
Headache
Dizziness
Individual responses may vary. This information is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before considering peptide-related therapies.
CJC-1295 No DAC vs. CJC-1295 with DAC: What’s the Difference?
Understanding the difference between the two forms is important when researching growth hormone peptides.
CJC-1295 with DAC
Contains a Drug Affinity Complex (DAC)
Binds to albumin in the bloodstream
Long-acting effect with a half-life of approximately 6–8 days
Produces sustained GH elevation
CJC-1295 No DAC (Mod GRF 1-29)
Does not contain DAC
Short half-life (30–60 minutes)
Promotes more physiological, pulsatile GH release
Requires more frequent administration
Its targeted mechanism makes it a common component in peptide-based wellness and performance protocols.
Where Can I Learn More?
1. Human clinical trial (gold standard study)
- Prolonged Stimulation of Growth Hormone and IGF-1 by CJC-1295
- Randomized, placebo-controlled trial showing significant increases in GH and IGF-1 levels in healthy adults after administration.
2. Growth hormone secretion & pulsatility study
- Pulsatile Secretion of Growth Hormone Persists with CJC-1295
- Demonstrated increased GH and IGF-1 levels while preserving natural pulsatile secretion patterns.
3. Mechanism & biomarker research (human study)
- Activation of the GH/IGF-1 Axis by CJC-1295
- Showed elevated GH/IGF-1 and associated protein changes, helping identify biomarkers of activity.
4. Preclinical growth & body composition study
- Once-Daily Administration of CJC-1295 in GHRHKO Mice
- Found improved growth, body composition, and increased GH expression in treated animals.
Common Stacks & Related Peptides
CJC-1295 combined with Ipamorelin is one of the most popular peptide stacks on the market as the two provide a powerful synergy to maximize growth hormone levels. It is also paired with other growth hormone analogs like Tesamorelin to maximize fat loss, especially belly visceral fat, while promoting lean muscle growth and improving body composition. For potent healing it is combined with BPC-157 to enhance healing, recovery, and tissue repair. CJC-1295 is widely used in the growth hormone category amongst adult researchers.
